NovaBridge Biosciences
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-152.7M | $-157.4M | $4.7M | $95.5M |
| FY2022 | $-159.9M | $-162.0M | $2.1M | $13.1M |
| FY2023 | $-183.8M | $-184.0M | $164.0K | $10.2M |
| FY2024 | $-52.7M | $-52.7M | $48.0K | $-1.9M |
| FY2025 | $-20.6M | $-20.6M | $7.0K | $6.0M |